Sign in

© 2026 ZeniX Life Sciences. All rights reserved. · Access restricted to authorised personnel (21 CFR Part 11 §11.10(d), EU Annex 11 §12.1).
Safety PV / Dashboard

Studies & Sites

Clinical studies, protocols, sites and investigators

StudyProtocolPhaseBlindingEudraCT / CTISINDStatus
Loading...

SUSAR Queue

Suspected unexpected serious adverse reactions awaiting assessment and expedited reporting

CaseStudyStatusClockDueDays leftFlags
Loading...

IB / RSI Library

Investigator's Brochures and Reference Safety Information versions

An uploaded version is a draft and does not affect expectedness until a Head of PV or admin other than the uploader approves it. Cases already evaluated are re-assessed by an override, edit or additional-information update.

Unblinding Requests

Emergency and regulatory unblinding requests, with audit trail

Line Listings

SUSAR and serious adverse event line listings by study and period

to

ICH E2F columns. The treatment arm is shown only to the unblinding officer and only after a case is unblinded; blinded cases show [BLINDED].

Investigator Notifications

SUSAR notifications to investigators and ethics committees

This screen keeps the record of each notification (pending, sent, acknowledged). It does not send email or contact anyone: send the notice yourself, then record it here with its reference.

Submissions (EVCTM / IND)

EudraVigilance clinical trials module and FDA IND safety report routing

Transmission disabled until gateway credentials are configured. This screen shows where each case would be routed and previews the E2B(R3) message with its validation result. Nothing is sent.

Dashboard

Post-marketing case processing, signals and periodic reporting

Awaiting review
—
 
Due today
—
Reports due before midnight
Overdue
—
Past the regulatory deadline
Returned
—
Escalated for correction
Open signals
—
Detected, awaiting assessment

My work

CaseStatusDeadline
Loading…

Upcoming deadlines

  • Loading…

Clinical Safety

Clinical-trial safety: SUSARs, DSUR, unblinding and investigator notifications — ICH E2A | E2F | EU CTR 536/2014 | 21 CFR 312.32

—
Total Cases
—
Expedited / Pending
—
Signals Detected
—
Pending Review
Trial Safety
SUSAR Queue
Serious unexpected related reactions with 7/15-day clocks and RSI-based expectedness.
Trial Cases
ICSRs reported from clinical studies (report type = clinical trial).
DSUR
Development Safety Update Reports per ICH E2F with SUSAR line listings.
Unblinding Requests
Controlled emergency and regulatory unblinding with a full audit trail.
Recent Cases
Last processed ICSR cases

No cases processed yet. Submit a report to get started.

System Status
Pipeline health overview
ICSR Pipeline Online
Signal Engine Online
Literature Monitor Online
Aggregate Reporting Online

Submit report

Paste or upload any incoming adverse event or quality complaint report for AI processing.

Sample Image (optional — for quality complaints)
No image selected
JPEG · PNG · WEBP · max 10MB · AI vision checks for defects, discoloration and foreign matter

Cases

Post-marketing Individual Case Safety Reports

Case Status Entered by Deadline Action
Loading cases...

Safety Product Master

Approvals per market, birth dates, reference safety information versions and exposure — the basis for periodic-report schedules, PADER/PSUR/DSUR case selection and expectedness.

ProductActive SubstanceMarketsIBDDIBDRSI Versions
Loading…

Companies & Projects

Who the safety data belongs to. Each client company (MAH / sponsor) has its own products, cases, reports and regulatory identity — the E2B safety report ID, gateway sender ID and safety contact.

CompanyCodeProject / servicesFDA gatewaySafety contactProductsCasesStatus
Loading…

Master Case Database

Search and filter every case, then export exactly what you see as CSV. De-identified (age group only, no patient/reporter identifiers).

Loading…
—
1

Signal Management

Step 1 of 2 — Disproportionality detection (PRR / ROR / BCPNN / EBGM). Detected signals are governed in

Signal Detection History
Previous detection runs
Report ID Generated Cases Analyzed Signals Strong Moderate Actions
Loading...

PSUR / PBRER

Periodic benefit-risk evaluation reports compiled from the case history — ICH E2C(R2)

Generate PSUR / PBRER
Approvals, CCDS, exposure and the MAH come from the product master — the ICH E2C(R2) tables need them.
Generated Reports
All PSUR/PBRER reports
Report ID Product Period Generated Total Cases Serious Expedited Actions
Loading...
Pharmacovigilance System Master File (PSMF)
GVP Module I — System overview, compliance status, and data quality metrics

Literature Monitor

Search PubMed, Europe PMC, Semantic Scholar and WHO IRIS — or paste an article — to screen for individual case reports (ICH E2B)

Case Workflow

Review, approve, and track cases through to regulatory submission

Awaiting me
›
Pending Review
›
Approved
›
Submitted
›
Closed
!
Escalated
All
Showing: All Cases
Case Stage Entered by Assigned to Deadline Action
Loading...

Case Form

Structured adverse event case entry — ICH E2B(R3) / MedDRA / 21 CFR compliant

Case ID: — New Case — Draft
Report Information
Reporter Information
Patient Identification
Physical & Demographics
Reproductive Status
Medical History & Concomitant Therapy
Structured History Entries
Product #1
Substance Information
Event #1
Diagnosis / Symptom Details
MedDRA Event Coding
Seriousness Criteria
Case Analysis
Classifications & Determinations
Contact Logs & Activities
Timestamp Description Group / User Code
Routing & Case Management
Notes & Attachments
References
Reference Type Reference ID Notes
Regulatory Report Details
Review & Submit

Process Logs

Per-stage pipeline traces — every step logged with timing, tokens, inputs & outputs

Raw JSON
Recent Runs —
Loading traces...

Select a trace on the left to see the full step-by-step log for that processing run.

Settings / Debug

Model configuration and diagnostic tools

Workflow Email (escalations, review tasks)
API Configuration
Health Check Open
API Documentation Open
LLM Call Logs Open
RAG Retrieval Debug Open
Available Models Open
System Health
Loading...
Two-Factor Authentication (MFA)
TOTP via Google Authenticator / Authy — 21 CFR Part 11 §11.300
MFA Not Enabled

Privacy & Compliance

HIPAA · GDPR · 21 CFR Part 11 · ICH E2B data protection controls

Data Protection Frameworks Active
✓ HIPAA Safe Harbour ✓ GDPR Pseudonymisation ✓ PHI Masking (AI Prompts) ✓ Audit Trail (21 CFR Part 11) ✓ GDPR Art. 30 Activity Log ⚠ BAA with Google pending ⚠ OAuth2 auth pending ⚠ DB encryption pending
GDPR Data Subject Rights
Loading...
Right to Erasure (GDPR Art. 17)

Pseudonymises direct identifiers. Safety data retained per ICH E2B / HIPAA §164.530(j).

PHI Masking — What Gets Masked
MASKED Patient name, email, phone, SSN, MRN, IP address, exact dates → before Gemini API calls
BANDED Exact patient age → 10-year band (e.g. 60–69). Never sent verbatim to external AI.
REMOVED Reporter name/email/phone stripped from API responses. Country & profession kept.
BLOCKED LOG_PROMPTS=false enforced — AI prompts with patient data never written to log files.
MINIMISED Signal detection AI receives only MedDRA terms + drug names, no demographics.
Privacy Audit Log

HIPAA §164.312(b) · GDPR Art. 30 · 21 CFR Part 11 §11.10(e)

Loading...
Lawful Basis for Processing
Primary: Art. 6(1)(c) Legal Obligation — ICSR reporting mandated by ICH E2B, 21 CFR 312.32, EU 726/2004
Special Category: Art. 9(2)(i) — Public health / pharmacovigilance purpose
Retention: 7 years minimum (HIPAA §164.530(j) / ICH E2B / 21 CFR 312)
GDPR Art. 30 — Records of Processing Activities

One entry per case — purpose, lawful basis, recipients, retention period, cross-border transfer basis.

Open Compliance Gaps — Action Required
Loading...
Data Retention Management

HIPAA §164.530(j) · GDPR Art. 5(1)(e) storage limitation · 21 CFR 312

Loading policy...
Security Controls Status
✓ API Key Authentication
X-API-Key header required on all write endpoints. SHA-256 hashed in memory.
✓ Role-Based Access Control
4 roles: admin · reviewer · analyst · readonly. Principle of least privilege.
✓ Rate Limiting
20 process/min · 5 signal detections/min · 120 reads/min per IP.
✓ Input Sanitisation
XSS strip · control char removal · 50KB max payload · script URI block.
✓ OWASP Security Headers
HSTS · CSP · X-Frame-Options · XSS-Protection · no-store cache on every response.
⚠ TLS/HTTPS
Configure TLS_CERT_FILE + TLS_KEY_FILE in .env. Required before production.
⚠ PostgreSQL + AES-256
Currently in-memory. DATABASE_URL in .env ready. Migrate for production.
⚠ Google BAA / DPA
Gemini API processes PHI. Business Associate Agreement + Data Processing Agreement required.

User management

Access control and audit trail — 21 CFR Part 11 §11.10(d)(e) · EU Annex 11 §12.1

System users

Loading users…

QPPV oversight

GVP Module I — benefit-risk and compliance overview for the Qualified Person for Pharmacovigilance

Overdue submissions
–
Past the regulatory deadline
Pending review
–
Cases in the 3-stage review
Unvalidated signals
–
Awaiting assessment
Open CAPAs
–
Corrective and preventive actions
Total ICSRs
–
All cases on record
Submitted to FDA
–
Sent to the agency
Regulatory Submissions
Loading…
Pending Review Cases
Loading…
Portfolio Risk by Product
Case Seriousness Mix

Deadline calendar

Submission deadlines for open cases — 7 days for fatal or life-threatening, 15 days for other serious reports (ICH E2A)

Overdue
–
Past the deadline, not yet submitted
Due in 3 days
–
Expedited reports needing action now
Upcoming
–
Later in the selected window
CaseStatusEntered byDeadlineAction
Loading…

Periodic reports

DSUR (ICH E2F) · RMP (EU GVP Module V) · PADER (21 CFR 314.80(c)(2))

Generate Development Safety Update Report
SUSAR listing for the DSUR period
Uses the period start / end above (the end date is the data lock point). The DSUR itself always covers the full interval (all SARs). This listing is for review and export.
No DSUR reports yet. Generate one above.

Signal lifecycle

GVP Module IX — triage, assess, validate and action signals found by disproportionality analysis

Signal Management runs statistical detection (PRR / ROR / BCPNN / EBGM) and surfaces candidate signals. Signal Lifecycle (this view) is where each candidate is clinically governed — triaged, assessed, validated, and actioned per EMA GVP Module IX §B.3–B.6. Signals appear here automatically after each detection run.
GVP IX Lifecycle States: Detected Triaged Assessed Validated Closed or Deferred Rejected
Signal Lifecycle Records
Run signal detection first, then transition signals through the GVP IX lifecycle here.

Analytics & KPIs

Submission timeliness, case volume trends, signal heatmap and CAPA status

Total ICSRs
–
All cases on record
7-day on time
–
Fatal / life-threatening reports
15-day on time
–
Other serious reports
Open CAPAs
–
Corrective and preventive actions
Overdue CAPAs
–
Past their due date
Review Efficiency — ZeniX AI Vigilance
–
Touchless rate
–
Hands-on time per case (median)
–
MedDRA coding agreement
StageNo edits in stage Mean hands-onMedDRA terms changed
Cases signed off at Stage 3 in the selected window. Idle gaps over 5 minutes are excluded from hands-on time.
Case Volume Trend (90 days)
Seriousness Breakdown
CAPA Status
MedDRA Top AE Terms
Portfolio Risk Scores
Signal Heatmap (Drug × AE — PRR)

Loading…

7-Day Submission Rate
–
15-Day Submission Rate
–
CAPA Actions Due in Next 30 Days
Loading…
Workflow SLA Performance
–
AI Predictive Outcome
Enter drug + AE term to predict seriousness probability using all 4 signal methods.
Cohort Comparison (Product A vs B)
Cohort A — Product Name
Cohort B — Product Name
PRR / ROR Signal Trend GVP Module IX §IX.C.1.2 — continuous signal monitoring
Signal Triage Queue GVP Module IX §IX.C.1.1 — pending clinical triage
Run signal detection, then refresh to see the triage queue.
CAPA Effectiveness ICH Q10 §3.2.3 / 21 CFR 211.192
–
Effectiveness Rate
–
Total CAPAs
–
Verified Effective
–
Recurrence Alerts

Signal Explainability — Feature Attribution

FDA AI/ML Guidance 2021/2024 §III.B — transparent AI decision factors

EMA EVDAS Signal Benchmark STUB

GVP Module IX §IX.C.2 — EV Gateway credentials pending (DEF-017)

Batch / Bulk Case Import

Import multiple cases from ZIP (E2B XML), CSV, or FHIR R4 Bundle

E2B(R3) structured import

One E2B(R3) XML file (a batch of one or more ICSRs) from an intake vendor, partner or other safety database. Fields are read as coded; no AI model is used and nothing leaves the system. Cases go to review. A report already imported is refused as a duplicate.

Import Cases
Audit Management
21 CFR Part 11 §11.10(e) — FDA Inspection Ready

Click Refresh to load audit events.

Training & Competency Management
GVP Module I — PV Personnel Qualification
SOP Document Control
GMP §211.68 — Controlled Document Management

Click Refresh to load SOPs.

System Configuration
Runtime settings — changes logged in audit trail (21 CFR Part 11)

Loading configuration...

Update Setting

IDMP Product Registry
ISO 11238–11239 — Identification of Medicinal Products

No products registered. Click Add Product to register a medicinal product.

Intake Queue

Every report that reaches us — email, web portal, phone, text message, EHR, literature, social media and partner systems. Valid reports become cases automatically; the rest wait here until someone completes them.

ReferenceReceivedChannelReporterSubject StatusMissing informationAcknowledgedCase
Loading…

Intake Channels

Where reports come from for each company, how reporters are thanked, and whether valid reports become cases automatically.

What is switched on
Loading…
Email
Web portal
Public link to give this company: /patient-portal
Phone & voicemail
Safety phone numbers
India: TRAI DLT sender header and template id are required before text messages can be sent.
Text messages (SMS)
Other channels
No automatic acknowledgement is sent for literature, social media, EHR or partner / API reports.
Acknowledgement identity
Automation
Valid reports (all four minimum criteria) become cases and go to Stage 1 review automatically; others wait here.

Integrations

LIMS / ERP Batch Record Integration
21 CFR 211.198(b) — retrieve manufacturing records for QC complaint investigations

Click Test Connection to check LIMS status.

Email Daemon — IMAP Ingestion
GVP Module VI — automated email-to-case pipeline; polls inbox every 5 minutes via Celery

Click Test Connection to check IMAP status.

Cloud Storage & Database Integration
ICH E2B(R3) — store submission packets, E2B XMLs and PDF reports in your own AWS, Azure, or GCP infrastructure
Amazon Web Services
S3 + RDS Aurora PostgreSQL

Click Test to check connectivity.

Microsoft Azure
Blob Storage + Azure SQL

Click Test to check connectivity.

Google Cloud Platform
Cloud Storage + BigQuery

Click Test to check connectivity.

Upload Document to Cloud
PubMed / Literature Surveillance Watchlist
ICH E2D §4.3.2 — automated daily literature monitoring for configured drug/AE pairs

No watchlist entries. Add a drug to start automated surveillance.

Surveillance Statistics
ICH E2D §4.3.2 / GVP Module VI Rev 2 §VI.B.2.1 — program metrics
–
Total Screened
–
ICSRs Detected
–
Detection Rate
–
High Relevance
–
Watchlist Entries
Source Breakdown
–
Action Distribution
–
Surveillance Results
Screened articles from automated PubMed / Europe PMC / Semantic Scholar / WHO IRIS runs

Loading…

Data Migration

Migrate historical ICSR cases from your AWS S3 bucket, Azure Blob Storage, or any ICH E2B(R3) XML source into ZeniX AI Vigilance.

AWS S3 → ZeniX AI Vigilance
Download E2B(R3) XML files from your S3 bucket and import all cases in bulk

Click Check Connection to verify S3 connectivity and estimate file count.

Migration runs in background. Duplicates are automatically skipped.

Data Sources

MedDRA licensed terminology integration · Production MAH case data for model augmentation

Loading MedDRA status…
MedDRA Term Search
Upload Licensed MedDRA Files

Select multiple .asc files (llt.asc, pt.asc, hlt.asc, hlgt.asc, soc.asc, etc.) downloaded from the MSSO subscriber portal.

Drop .asc files here or click to browse
Multiple files accepted
MSSO Licence Guide
Loading…

AI Assistant

Evidence-Based Pharmacovigilance Expert
Case data & narrative FAERS background rates Literature surveillance RAG regulatory refs Cross-case statistics ICH / GVP / FDA 21 CFR
Try:
Hello! I'm your ZeniX AI Vigilance Expert.

I can answer evidence-based questions using case data, FAERS background rates, screened literature, and regulatory guidance (ICH E2A/E2B, GVP, FDA 21 CFR).

Every claim will cite its exact source field. Try a suggested question above, or type your own.
0/2000

Stage Test Console